Applying a Novel Integrated Persistent Feature to Understand Topographical Network Connectivity in Older Adults with Autism Spectrum Disorder

157470-Thumbnail Image.png
Description
Autism spectrum disorder (ASD) is a developmental neuropsychiatric condition with early childhood onset, thus most research has focused on characterizing brain function in young individuals. Little is understood about brain function differences in middle age and older adults with ASD,

Autism spectrum disorder (ASD) is a developmental neuropsychiatric condition with early childhood onset, thus most research has focused on characterizing brain function in young individuals. Little is understood about brain function differences in middle age and older adults with ASD, despite evidence of persistent and worsening cognitive symptoms. Functional Magnetic Resonance Imaging (MRI) in younger persons with ASD demonstrate that large-scale brain networks containing the prefrontal cortex are affected. A novel, threshold-selection-free graph theory metric is proposed as a more robust and sensitive method for tracking brain aging in ASD and is compared against five well-accepted graph theoretical analysis methods in older men with ASD and matched neurotypical (NT) participants. Participants were 27 men with ASD (52 +/- 8.4 years) and 21 NT men (49.7 +/- 6.5 years). Resting-state functional MRI (rs-fMRI) scans were collected for six minutes (repetition time=3s) with eyes closed. Data was preprocessed in SPM12, and Data Processing Assistant for Resting-State fMRI (DPARSF) was used to extract 116 regions-of-interest defined by the automated anatomical labeling (AAL) atlas. AAL regions were separated into six large-scale brain networks. This proposed metric is the slope of a monotonically decreasing convergence function (Integrated Persistent Feature, IPF; Slope of the IPF, SIP). Results were analyzed in SPSS using ANCOVA, with IQ as a covariate. A reduced SIP was in older men with ASD, compared to NT men, in the Default Mode Network [F(1,47)=6.48; p=0.02; 2=0.13] and Executive Network [F(1,47)=4.40; p=0.04; 2=0.09], a trend in the Fronto-Parietal Network [F(1,47)=3.36; p=0.07; 2=0.07]. There were no differences in the non-prefrontal networks (Sensory motor network, auditory network, and medial visual network). The only other graph theory metric to reach significance was network diameter in the Default Mode Network [F(1,47)=4.31; p=0.04; 2=0.09]; however, the effect size for the SIP was stronger. Modularity, Betti number, characteristic path length, and eigenvalue centrality were all non-significant. These results provide empirical evidence of decreased functional network integration in pre-frontal networks of older adults with ASD and propose a useful biomarker for tracking prognosis of aging adults with ASD to enable more informed treatment, support, and care methods for this growing population.
Date Created
2019
Agent

Design and Development of Injectable, Wireless, Sub-Millimeter Neurostimulators

133764-Thumbnail Image.png
Description
An improved system for wireless neurostimulation was investigated through the design and development of sub-millimeter piezoelectric devices. The devices build on prior work in the lab, which was limited by device size and required surgical implantation. A method of manufacturing

An improved system for wireless neurostimulation was investigated through the design and development of sub-millimeter piezoelectric devices. The devices build on prior work in the lab, which was limited by device size and required surgical implantation. A method of manufacturing sub-mm devices was developed, and utilized to construct this new design. The device frequency response was characterized and its resonant modes and output voltages determined through a Fast Fourier Transform. The fundamental thickness mode frequency was found to be 15.4MHz with a corresponding 10.25mV amplitude, and a longitudinal resonant frequency of 3.1Mhz with a corresponding 2.2mV amplitude across a 50Ω resistor. The high miniaturization of the device holds promise for future work for creating an injectable, wireless system for the treatment of neurological disorders.
Date Created
2018-05
Agent